Xerient
2 known investors
Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
Founders & leadership
GY
Guy YachininCo-Founder & CEO
DM
Dr. Michael ShteinCo-Founder & CSO
PC
Prof. Cullen TaniguchiCo-Founder
Investors · 2
Frequently asked questions
- What does Xerient do?
- Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
- Who founded Xerient?
- Xerient was founded by Guy Yachin, Dr. Michael Shtein, Prof. Cullen Taniguchi.
- Who are Xerient's investors?
- Xerient's investors include Peregrine Ventures, SIBF (Southern Israel Bridging Fund) VC.